Publications

5674 Results

Combined hepatic chemoembolization (CE) and systemic continuous infusion 5-FU (CIFU) + leucovorin (LV) for metastatic colorectal cancer (MCC): A phase II Southwest Oncology Group trial.

Authors
CG Leichman;J Jacobson;M Zalupski;L Leong;J Benedetti
Journal / Conference
American Society of Clinical Oncology 15:215(#500)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9051

Phase II trial of B-trans-retinoic acid (TRA) in primary hepatomas (SWOG-9157).

Authors
FL Meyskens Jr;B Nguyen;J Jacobson;J Macdonald
Journal / Conference
American Society of Clinical Oncology 15:229(#559)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9157

Edatrexate and carboplatin in stage IV non-small cell lung cancer: Phase II trial of the Southwest Oncology Group (SWOG).

Authors
D Gandara;M Edelman;G Smith;J Crowley;R Livingston
Journal / Conference
American Society of Clinical Oncology 15:397(#1202)
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9207

Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated malignant melanoma: A Southwest Oncology Group (SWOG) study.

Authors
RP Whitehead;J Unger;SP Balcerzak;JW Goodwin;SE Rivkin;LE Flaherty;VK Sondak
Journal / Conference
American Society of Clinical Oncology 15:438(#1363)
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9228

Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated renal cell adenocarcinoma: A Southwest Oncology Group (SWOG) study.

Authors
RP Whitehead;B Blumenstein;RC Flanigan;GR Weiss;DJ Culkin;SI Bearman;S Dakhil;ED Crawford
Journal / Conference
American Society of Clinical Oncology 15:259(#672)
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9230

Phase II trial of casodex in advanced prostate cancer (CaP) patients who failed conventional hormonal manipulation: A Southwest Oncology Group (SWOG) study (SWOG9235).

Authors
O Kucuk;B Blumenstein;C Moinpour;D Lew;D Coleman;M Eisenberger;D Crawford
Journal / Conference
American Society of Clinical Oncology 15:245(#618)
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9235

A randomized trial of paclitaxel (T) at 2 dose levels and filgrastim (G; G-CSF) at 2 doses in platinum (P) pretreated epithelial ovarian cancer (OVCA): A Gynecologic Oncology Group, SWOG, NCCTG and ECOG study.

Authors
GA Omura;MF Brady;JE Delmore;HJ Long;KY Look;HE Averette;S Wadler;G Spiegel
Journal / Conference
American Society of Clinical Oncology 15:280(#755)
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)

A phase II trial of paclitaxel in patients with metastatic refractory carcinoma of the breast: A Southwest Oncology Group (SWOG) study.

Authors
CE Geyer Jr;SJ Green;C Moinpour;J O'Sullivan;D Goodwin;V Canfield;V Hamaski;S Martino
Journal / Conference
American Society of Clinical Oncology 15:107(#92)
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-9248

bcl-2, p53, and response to tamoxifen in er-positive metastatic breast cancer.

Authors
R Elledge;S Green;L Howes;M Berardo;DC Allred;D Ciocca;CK Osborne;P Ravdin;J O'Sullivan;G Langone
Journal / Conference
American Society of Clinical Oncology 15:123(#159)
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Gender differences and independent predictors of survival in patients with metastatic malignant melanoma on SWOG trials.

Authors
L Flaherty;J Unger;PY Liu;K Albain;V Sondak
Journal / Conference
American Society of Clinical Oncology 15:433(#1344)
Year
1996
Research Committee(s)
Melanoma